Zhigao Song
Cong Chen
Jipei He
Bixia Liu1
Weidong Ji
Liangping Wu
Li He
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
- 2Department of Cardiovascular Surgery, Zhujiang Hospital of Southern Medical University, Guangzhou, China
- 3Department of Metabolic Surgery, Your Doctor Medical Group, Guangzhou, China
- 4Department of Metabolic Surgery, Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China
- 5Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
A Corrigendum on
ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes
By Song Z, Chen C, He J, Liu B, Ji W, Wu L and He L (2022). Front. Endocrinol. 13:896753. doi: 10.3389/fendo.2022.896753
Error in author list
In the published article, there was an error in the author list, and author Weidong Ji 1 was erroneously cited. The corrected author list appears below.
Zhigao Song 1,2†, Cong Chen 1†, Jipei He 3, Bixia Liu 1, Weidong Ji 1*, Liangping Wu 3,4* and Li He 1,5*
The authors apologize for this error and state that this does not change the scientific conclusiosns of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: AIP1, visceral adipose, adipose inflammation, insulin resistance, type 2 diabetes
Citation: Song Z, Chen C, He J, Liu B, Ji W, Wu L and He L (2022) Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes. Front. Endocrinol. 13:981231. doi: 10.3389/fendo.2022.981231
Received: 29 June 2022; Accepted: 28 July 2022;
Published: 16 August 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Song, Chen, He, Liu, Ji, Wu and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Li He, aGVsaTU1QG1haWwuc3lzdS5lZHUuY24=; Liangping Wu, ZHJ3dWxwQDE2My5jb20=; Weidong Ji, aml3ZWlkb25nQG1haWwuc3lzdS5lZHUuY24=
†These authors have contributed equally to this work